Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Lepu Scientech Medical Technology Shanghai Co Ltd (2291)

Hong Kong
Currency in HKD
Disclaimer
23.50
0.00(0.00%)
Closed
2291 Scorecard
Fair Value
Day's Range
22.6523.85
52 wk Range
21.5535.50
Bid/Ask
23.10 / 23.50
Prev. Close
23.5
Open
23
Day's Range
22.65-23.85
52 wk Range
21.55-35.5
Volume
114,000
Average Vol. (3m)
123,475
1-Year Change
-12.15%
Shares Outstanding
1,659,444,838
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
How do you feel today about 2291?
Vote to see community's results!
or

Lepu Scientech Medical Technology Shanghai Co Ltd Company Profile

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics products in China. The company offers HX008, a humanized IgG4 mAb against human PD-1for the treatment of solid tumors and melanoma. It is conducting phase III clinical study of HX008 in combination therapy with irinotecan, and Phase II clinical trials of HX008 for non-small cell lung cancer, triple-negative breast cancer, and hepatocellular carcinoma. It is also developing MRG003 for nasopharyngeal cancer, and head and neck squamous cell carcinoma and is in phase II clinical study; and MRG002, which is in phase II trials for treatment of gastric cancer, gastroesophageal junction, and urothelial cancer. Further, it is developing MRG001 CD20-targeted ADC and CMG9013 CLDN18.2-targeted ADC that are in phase II trials; and MRG004A TF-targeted ADC that is in phase 1 trials. The company was incorporated in 2018 and is headquartered in Shanghai, China.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.